These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31949745)

  • 1. Targeted next-generation sequencing in cytology specimens for molecular profiling of lung adenocarcinoma.
    Zhang Y; Li J; Hua P; Liu N; Li Q; Zhu X; Jiang L; Zheng K; Su X
    Int J Clin Exp Pathol; 2018; 11(7):3647-3655. PubMed ID: 31949745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
    Karnes HE; Duncavage EJ; Bernadt CT
    Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
    Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
    Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Next-Generation Sequencing, Quantitative PCR, and Sanger Sequencing for Mutation Profiling of EGFR, KRAS, PIK3CA and BRAF in Clinical Lung Tumors.
    Gao J; Wu H; Shi X; Huo Z; Zhang J; Liang Z
    Clin Lab; 2016; 62(4):689-96. PubMed ID: 27215089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens.
    Liu L; Shao D; Deng Q; Tang H; Wang J; Liu J; Guo F; Lin Y; Peng Z; Mao M; Kristiansen K; Ye M; He J
    J Thorac Dis; 2018 May; 10(5):2631-2637. PubMed ID: 29997924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
    Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.
    Buttitta F; Felicioni L; Del Grammastro M; Filice G; Di Lorito A; Malatesta S; Viola P; Centi I; D'Antuono T; Zappacosta R; Rosini S; Cuccurullo F; Marchetti A
    Clin Cancer Res; 2013 Feb; 19(3):691-8. PubMed ID: 23243218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis.
    Yamaguchi T; Akahane T; Harada O; Kato Y; Aimono E; Takei H; Tasaki T; Noguchi H; Nishihara H; Kamata H; Tanimoto A
    Diagn Cytopathol; 2020 Nov; 48(11):965-971. PubMed ID: 32511899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.
    Xu X; Yang Y; Li H; Chen Z; Jiang G; Fei K
    Scand J Clin Lab Invest; 2016 Sep; 76(5):386-92. PubMed ID: 27215271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.
    Jain D; Ramachandrappa VS; Singh V; Malik PS; Madan K; Faruq M; Guleria R
    Acta Cytol; 2017; 61(6):455-461. PubMed ID: 28848083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F; Zheng X; Mao X; Zhao R; Ye J; Zhang Y; Sun J
    Ann Thorac Surg; 2019 Jul; 108(1):219-226. PubMed ID: 30885850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
    Reynolds JP; Zhou Y; Jakubowski MA; Wang Z; Brainard JA; Klein RD; Farver CF; Almeida FA; Cheng YW
    Cancer Cytopathol; 2017 Mar; 125(3):178-187. PubMed ID: 28085233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing guidelines for lung adenocarcinoma: Utility of cell blocks and concordance between fine-needle aspiration cytology and histology samples.
    Heymann JJ; Bulman WA; Maxfield RA; Powell CA; Halmos B; Sonett J; Beaubier NT; Crapanzano JP; Mansukhani MM; Saqi A
    Cytojournal; 2014; 11():12. PubMed ID: 24987443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.
    Yamamoto G; Kikuchi M; Kobayashi S; Arai Y; Fujiyoshi K; Wakatsuki T; Kakuta M; Yamane Y; Iijima Y; Mizutani H; Nakajima Y; Sudo J; Kinoshita H; Kurimoto F; Akiyama H; Uramoto H; Sakai H; Akagi Y; Akagi K
    Int J Oncol; 2017 May; 50(5):1579-1589. PubMed ID: 28350094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation.
    Fernandes MGO; Jacob M; Martins N; Moura CS; Guimarães S; Reis JP; Justino A; Pina MJ; Cirnes L; Sousa C; Pinto J; Marques JA; Machado JC; Hespanhol V; Costa JL
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
    Gailey MP; Stence AA; Jensen CS; Ma D
    Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.